Demystifying the nuances of the lipid patient: a guide for primary care providers

Atherosclerosis, a major cause of mortality and morbidity in the United States (US), is driven by complex factors, including the cumulative burden of low-density lipoprotein cholesterol (LDL-C) and other atherogenic lipids and lipoproteins. Lipid management in US primary care aims to prevent atheros...

Full description

Bibliographic Details
Published in:	American Journal of Preventive Cardiology
Main Authors:	Merle Myerson, Kyle Gillett, James O’Hara, Richard Potter, Neil Skolnik
Format:	Article
Language:	English
Published:	Elsevier 2025-09-01
Subjects:	Atherosclerosis ASCVD Lipid screening Lipid-lowering therapy Primary care ASCVD risk scoring
Online Access:	http://www.sciencedirect.com/science/article/pii/S266666772500145X

Similar Items

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020-12-01)

Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems
by: Nishant P. Shah, et al.
Published: (2024-11-01)

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
by: Chad Gier, et al.
Published: (2024-01-01)

Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins
by: Fei Luo, et al.
Published: (2024-01-01)

Secondary Cardiovascular Disease Prevention Deficit Persists over the Years: A Multicenter Cross-Sectional Study Involving 1003 Consecutive Patients from Greece
by: Rodis D. Paparodis, et al.
Published: (2024-03-01)

Lipoprotein(a) Testing for Cardiovascular Risk Assessment and Use of Lipid-Lowering Therapy in a Large Midwest Cohort
by: Felipe Villa Martignoni, et al.
Published: (2025-09-01)

Knowledge, awareness, and attitude among pharmacists regarding the risk estimation of cardiovascular disease in Jordan: Immersion of lipid-lowering agents
by: Abeer M. Rababa'h, et al.
Published: (2023-09-01)

Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease
by: Jie Liu, et al.
Published: (2025-07-01)

Audit on lipid screening, management and target achievement in prevention of cardiovascular disease in patients attending a medical clinic in National Hospital Kandy: Are we on par with the guidelines?
by: F. N. Nasim, et al.
Published: (2023-02-01)

Managing dyslipidaemia in patients with chronic kidney disease
by: Ashwani Mehta
Published: (2024-03-01)

Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting
by: Arrigo F. G. Cicero, et al.
Published: (2023-12-01)

Stationary screen time, blood lipids, and atherosclerotic cardiovascular disease incidence
by: Yunjie Liu, et al.
Published: (2025-03-01)

Impact of remnant cholesterol to high-density lipoprotein cholesterol ratio on risk of incident ASCVD: the Kailuan prospective cohort study
by: Yizhen Tan, et al.
Published: (2025-05-01)

Subclinical cardiovascular disease and utility of coronary artery calcium score
by: Cihan Durmuş Saydam
Published: (2021-12-01)

Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease
by: Xiao-Lan Zhao, et al.
Published: (2025-01-01)

HDL-Based Therapy: Vascular Protection at All Stages
by: Anastasia V. Poznyak, et al.
Published: (2023-02-01)

Increasing provider awareness of Lp(a) testing for patients at risk for cardiovascular disease: A comparative study
by: Wael E. Eid, et al.
Published: (2025-03-01)

Managing dyslipidaemia in young adults
by: Jamshed J. Dalal, et al.
Published: (2024-03-01)

Self- vs provider-referral differences for coronary artery calcium testing
by: Rebekah Lantz, et al.
Published: (2022-01-01)

The interaction between blood lipids and ASCVD increases the risk of DKD: a nonlinear relationship transforms into a linear relationship, a cross-sectional study
by: Huan Li, et al.
Published: (2025-08-01)

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
by: Danh Q. Nguyen, et al.
Published: (2024-06-01)

QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores
by: Subramanian Kannan, et al.
Published: (2024-12-01)

Advancements in research to mitigate residual risk of atherosclerotic cardiovascular disease
by: Fan Shi, et al.
Published: (2025-08-01)

Dyslipidemia management among patients with high and very high cardiovascular risk in Indonesia: a multi-center registry
by: Sunanto Ng, et al.
Published: (2025-09-01)

Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China
by: Min Liu, et al.
Published: (2024-12-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
by: Zain Jafar, et al.
Published: (2020-09-01)

Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease
by: Dean G. Karalis, et al.
Published: (2023-06-01)

A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study
by: Yu-Chung Hsiao, et al.
Published: (2024-06-01)

Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol
by: Maureen Sampson, et al.
Published: (2022-07-01)

Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA)
by: Jian H. Chu, et al.
Published: (2022-09-01)

Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study
by: Xingdi Hu, et al.
Published: (2023-06-01)

Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature
by: Shahla V Esfarjani, et al.
Published: (2022-01-01)

Atherosclerotic cardiovascular disease risk among Ghanaians: A comparison of the risk assessment tools.
by: Francis Agyekum, et al.
Published: (2024-06-01)

Comparative 10-year atherosclerotic cardiovascular disease risk in Ethiopian HIV patients on first-line versus second-line combined antiretroviral therapy
by: Balew Arega, et al.
Published: (2025-09-01)

PREVENT Risk Score vs the Pooled Cohort Equations in MESA
by: Brittany Saldivar Murphy, MD, et al.
Published: (2025-06-01)

What motivates participants: a qualitative analysis of gamification and financial incentives to increase physical activity
by: Eric Ryu, et al.
Published: (2025-05-01)

A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease
by: Xiaochun Duan, et al.
Published: (2025-02-01)

Cardiology patients are unaware of the benefits of seasonal influenza immunization
by: Sarah R. Monagle, et al.
Published: (2024-09-01)

Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women
by: Betânia Rodrigues dos Santos, et al.
Published: (2025-01-01)